{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:10:48Z","timestamp":1777425048316,"version":"3.51.4"},"reference-count":50,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T00:00:00Z","timestamp":1190851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is the third most common cause of cancer\u2010related death, and its incidence is increasing worldwide. Due to the known risk factors (mainly hepatitis B and C viruses), we believe there is a rationale for a chemopreventive approach to treat HCC. Here, based on described <jats:italic>in vitro <\/jats:italic>data, we evaluated the preventive effects of lanreotide, a somatostatin analog, on the induction of early carcinogenic events. We monitored preneoplastic foci induced by a two\u2010stage initiation\/promotion model of hepatocarcinogenesis in male Wistar rats, using diethylnitrosamine and 2\u2010acetylaminofluorene. Lanreotide was given starting the day after the first diethylnitrosamine injection. By quantitative morphometry, we showed that lanreotide significantly decreases the size of induced preneoplastic foci. Analysis of proliferation and apoptosis assessed by immunohistochemistry, showed decreased proliferation and increased cell death in rats treated with lanreotide. As these events were associated with a significant decreased expression of the cell cycle regulator cyclin D1 and an increased expression of the cyclin\u2010dependent kinase inhibitor p27<jats:sup>kip1<\/jats:sup> compared to the non\u2010treated group, it is tempting to speculate that these factors are involved in the favorable effect of lanreotide. In conclusion, lanreotide significantly decreases early carcinogenic transformation in a two\u2010step rat model. As lanreotide has a low toxicity profile, we believe it would be interesting to evaluate its effect in chemoprevention of HCC. (<jats:italic>Cancer Sci<\/jats:italic> 2007; 98: 1831\u20131839)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2007.00626.x","type":"journal-article","created":{"date-parts":[[2007,9,29]],"date-time":"2007-09-29T04:12:52Z","timestamp":1191039172000},"page":"1831-1839","source":"Crossref","is-referenced-by-count":13,"title":["Inhibition of early preneoplastic events in the rat liver by the somatostatin analog lanreotide"],"prefix":"10.1111","volume":"98","author":[{"given":"Ivan","family":"Borbath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle A.","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Abarca\u2010Quinones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Desaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sempoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Horsmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,9,27]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1440"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401001"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/0192623389017004111"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(11)80394-8"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408448609037071"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/263701a0"},{"key":"e_1_2_6_8_2","first-page":"2076","article-title":"Kinetics of formation and persistence of ethylguanines in DNA of rats and hamsters treated with diethylnitrosamine","volume":"45","author":"Becker RA","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1481"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/15.9.1939"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl105"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002590100541"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.036053"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.5.766"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.03.018"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27971"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.1.251"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-003-0447-5"},{"key":"e_1_2_6_19_2","first-page":"1167","article-title":"Antineoplastic mechanism of Octreotide action in human hepatoma","volume":"114","author":"Chen X","year":"2001","journal-title":"Chin Med J (Engl)"},{"key":"e_1_2_6_20_2","first-page":"1380","article-title":"Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells","volume":"25","author":"Liu HL","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.01.016"},{"key":"e_1_2_6_22_2","first-page":"1197","article-title":"Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo","volume":"16","author":"Raderer M","year":"2000","journal-title":"Int J Oncol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(97)90385-7"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1200\/jco.2005.23.16_suppl.4036","article-title":"Treatment of advanced hepatocellular carcinoma with long\u2010acting octreotide: preliminary results of a randomized placebo\u2010controlled trial (FFCD\u2010ANGH 2001\u201301 CHOC)","volume":"23","author":"Barbare JC","year":"2005","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.3.442"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.35071"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603325"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21468"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/18.3.545"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/endo.142.1.7908","article-title":"Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42\/p44 mitogen\u2010activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells","volume":"142","author":"Charland S","year":"2001","journal-title":"Endocrinology"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32099"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-2607(02)00115-3"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1289"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63852-7"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00005-8"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.9409"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1323.2001.02054.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(00)00148-0"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904013401315"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh028"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.01.030"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.30.040190.002341"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/15.11.2587"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/9.2.221"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(96)00063-0"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90148-5"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/8.11.1585"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.21.15186"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203388200"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.7.1231"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1999.4397"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2007.00626.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2007.00626.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:50:02Z","timestamp":1697187002000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2007.00626.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,27]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1349-7006.2007.00626.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00626.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,27]]}}}